Next Article in Journal
The Full Value of Vaccine Assessments Concept—Current Opportunities and Recommendations
Previous Article in Journal
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases
Previous Article in Special Issue
Return on Investment (ROI) of Three Vaccination Programmes in Italy: HPV at 12 Years, Herpes Zoster in Adults, and Influenza in the Elderly
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 434; https://doi.org/10.3390/vaccines12040434
Action Date Notes Link
article xml file uploaded 18 April 2024 10:38 CEST Original file -
article xml uploaded. 18 April 2024 10:38 CEST Update https://www.mdpi.com/2076-393X/12/4/434/xml
article pdf uploaded. 18 April 2024 10:38 CEST Version of Record https://www.mdpi.com/2076-393X/12/4/434/pdf
article supplementary file uploaded. 18 April 2024 10:38 CEST - https://www.mdpi.com/2076-393X/12/4/434#supplementary
article html file updated 18 April 2024 10:40 CEST Original file https://www.mdpi.com/2076-393X/12/4/434/html
Back to TopTop